Private Domain Marketing Involved Hainan Pharmaceutical Factory Involved in Multiple Legal Disputes

LightningPacketLoss · 2026-03-16T03:19:08+00:00

On March 15th, CCTV's 315 Evening Party exposed the "expert mystery" in private domain marketing, with Hainan Pharmaceutical Factory Limited Company being called out. According to Tianyancha App, Hainan Pharmaceutical Factory Limited Company was established in July 2001, with Li Youfeng as the legal representative, registered capital of RMB 12.8 million, and business scope including production of chemical pharmaceuticals, tablets, capsules, granules, etc., processing of supplied materials, automobile transportation, and other operations. The company is jointly held by Li Youfeng, Dou Zhi, Wei Maoxiu, and others. Tianyan risk information shows that the company is involved in multiple judicial case records, with case categories involving disputes over sales contracts, disputes over life rights, bodily rights, and health rights.

LightningPacketLoss

2026-03-16 03:19:08

On March 15, the CCTV 315 Gala exposed the mystery of experts in private domain marketing, and Hainan Pharmaceutical Factory Co., Ltd. was named. Tianyancha app shows that Hainan Pharmaceutical Factory Co., Ltd. was established in July 2001. The legal representative is Li Youfeng, with a registered capital of 12.8 million RMB. Its business scope includes the production of chemical drug preparations, tablets, capsules, granules, and other products, as well as processing and automobile transportation. The company is jointly held by Li Youfeng, Dou Zhi, Wei Maoxiu, and others. Tianyancha risk information indicates that the company is involved in multiple judicial cases, including disputes over sales contracts, and disputes related to the right to life, physical rights, and health rights.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.